Mechanism of aging of mipafox-inhibited butyrylcholinesterase

Chemical Research in Toxicology

Volumn 20, Issue 3, 2007, Pages 504-510

  Kropp, Timothy J ^a   Richardson, Rudy J ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE; ISOPROPYLAMINE; MIPAFOX; N,N' DIISOPROPYLPHOSPHOFLUORIDATE; NEUROTOXIC ESTERASE; ORGANOPHOSPHORUS COMPOUND; PROPYLAMINE; UNCLASSIFIED DRUG;

AGING; ARTICLE; AUTOLYSIS; CATALYSIS; CONTAMINATION; ENZYME INHIBITION; GLYCOSYLATION; PROTON TRANSPORT; SPECTROSCOPY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

AGING; ANIMALS; BINDING SITES; BUTYRYLCHOLINESTERASE; CARBOXYLIC ESTER HYDROLASES; CHOLINESTERASE INHIBITORS; CRYSTALLOGRAPHY, X-RAY; HORSES; ISOFLUROPHATE; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 34047272804     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx600310y     Document Type: Article

References (40)

1. Thompson, C. M., and Richardson, R. J. (2004) Anticholinesterase insecticides. In Pesticide Toxicology and International Regulation (Marrs, T. C., and Ballantyne, B., Eds.) pp 89-127, John Wiley and Sons, Ltd., Chichester, U.K.
2. Casida, J. E., and Quistad, G. B. (2005) Serine hydrolase targets of organophosphorus toxicants. Chem.-Biol. Interact. 157-158, 277-283.
3. Aldridge, W. N., and Reiner, R. E. (1972) Enzyme Inhibitors as Substrates: Interactions of Esterases with Esters of Organophosphorus and Carbamic Acids. North-Holland Publishing Company, Amsterdam.
4. Nicolet, Y., Lockridge, O., Masson, P., Fontecilla-Camps, J. C., and Nachon, F. (2003) Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. J. Biol. Chem. 278, 41141-41147.
5. Fidder, A., Hulst, A. G., Noort, D., de Ruiter, R., van der Schans, M. J., Benschop, H. P., and Langenberg, J. P. (2002) Retrospective detection of exposure to organophosphorus anti-cholinesterases: mass spectrometric analysis of phosphylated human butyrylcholinesterase. Chem. Res. Toxicol. 15, 582-590.
6. Doom, J. A., Talley, T. T., Thompson, C. M., and Richardson, R. J. (2001) Probing the active sites of butyrylcholinesterase and cholesterol esterase with isomalathion: conserved stereoselective inactivation of serine hydrolases structurally related to acetylcholinesterase. Chem. Res. Toxicol. 14, 807-813.
7. Doom, J. A., Schall, M., Gage, D. A., Talley, T. T., Thompson, C. M., and Richardson, R. J. (2001) Identification of butyrylcholinesterase adducts after inhibition with isomalathion using mass spectrometry: difference in mechanism between (1R)- and (1S)-stereoisomers. Toxicol. Appl. Pharmacol. 176, 73-80.
8. Jennings, L. L., Malecki, M., Komives, E. A., and Taylor, P. (2003) Direct analysis of the kinetic profiles of organophosphate-acetylcholinesterase adducts by MALDI-TOF mass spectrometry. Biochemistry 42, 11083-11091.
9. Doorn, J. A., Gage, D. A., Schall, M., Talley, T. T., Thompson, C. M., and Richardson, R. J. (2000) Inhibition of acetylcholinesterase by (1S,3S)-isomalathion proceeds with loss of thiomethyl: kinetic and mass spectral evidence for an unexpected primary leaving group. Chem. Res. Toxicol. 13, 1313-1320.
10. Doom, J. A., Thompson, C. M., Christner, R. B., and Richardson, R. J. (2003) Stereoselective inactivation of Torpedo califomica acetylcholinesterase by isomalathion: inhibitory reactions with (1R)- and (1S)-isomers proceed by different mechanisms. Chem. Res. Toxicol. 16, 958-965.
11. Elhanany, E., Ordentlich, A., Dgany, O., Kaplan, D., Segall, Y., Barak, R., Velan, B., and Shafferman, A. (2001) Resolving pathways of interaction of covalent inhibitors with the active site of acetylcholinesterases: MALDI-TOF/MS analysis of various nerve agent phosphyl adducts. Chem. Res. Toxicol. 14, 912-918.
12. Kropp, T. J., and Richardson, R. J. (2006) Aging of mipafox-inhibited human acetylcholinesterase proceeds by displacement of both isopropylamine groups to yield a phosphate adduct. Chem. Res. Toxicol. 19, 334-339.
13. Millard, C. B., Kryger, G., Ordentlich, A., Greenblatt, H. M., Harel, M., Raves, M. L., Segall, Y., Barak, D., Shafferman, A., Silman, I., and Sussman, J. L. (1999) Crystal structures of aged phosphonylated acetylcholinesterase: nerve agent reaction products at the atomic level. Biochemistry 38, 7032-7039.
14. Masson, P., Fortier, P. L., Albaret, C., Froment, M. T., Bartels, C. F., and Lockridge, O. (1997) Aging of di-isopropyl-phosphorylated human butyrylcholinesterase. Biochem. J. 327, 601-607.
15. Masson, P., Froment, M. T., Bartels, C. F., and Lockridge, O. (1997) Importance of aspartate-70 in organophosphate inhibition, oxime reactivation and aging of human butyrylcholinesterase. Biochem. J. 325, 53-61.
16. Nachon, F., Asojo, O. A., Borgstahl, G. E. O., Masson, P., and Lockridge, O. (2005) Role of water in aging of human butyrylcholinesterase inhibited by echothiophate: The crystal structure suggests two alternative mechanisms of aging. Biochemistry 42, 1154-1162.
17. 31P NMR spectroscopy. Biochemistry 32, 13441-13450.
18. Williams, D. G. (1983) Intramolecular group transfer is a characteristic of neurotoxic esterase and is independent of the tissue source of the enzyme. A comparison of the aging behaviour of di-isopropyl phosphorofluoridate-labeled proteins in brain, spinal cord, liver, kidney and spleen from hen and in human placenta. Biochem. J. 209, 817-829.
19. Williams, D. G., and Johnson, M. K. (1981) Gel-electrophoretic identification of hen brain neurotoxic esterase, labeled with tritiated di-isopropyl phosphorofluoridate. Biochem. J. 199, 323-333.
20. Kropp, T. J., Glynn, P., and Richardson, R. J. (2004) The mipafox-inhibited catalytic domain of human neuropathy target esterase ages by reversible proton loss. Biochemistry 43, 3716-3722.
21. Milatovic, D., and Johnson, M. K. (1993) Reactivation of phosphoramidated acetylcholinesterase and neuropathy target esterase by treatment of inhibited enzyme with potassium fluoride. Chem.-Biol. Interact. 87, 425-430.
22. Wierdl, M., Morton, C. L., Danks, M. K., and Potter, P. M. (2000) Isolation and characterization of a cDNA encoding a horse liver butyrylcholinesterase. Evidence for CPT-11 drug activation. Biochem. Pharmacol. 59, 773-781.
23. Ellman, G., Courtney, K. D., Andres, V., Jr., and Featherstone, R. M. (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88-95.
24. Clothier, B., Johnson, M. K., and Reiner, E. (1981) Interaction of some trialkyl phosphorothiolates with acetylcholinesterase: characterization of inhibition, aging and reactivation. Biochim. Biophys. Acta 660, 306-316.
25. Jianmongkol, S., Marable, B. R., Berkman, C. W., Tally, T. T., Thompson, C. M., and Richardson, R. J. (1999) Kinetic evidence for different mechanisms of acetylcholinesterase inhibition by (1R)- and (1S)-stereoisomers of isomalathion. Toxicol. Appl. Pharmacol. 155, 43-53.
26. Cousin, X., Hotellier, T., Giles, K., Toutant, J. P., and Chatonnet, A. (1998) aCHEdb: the database system for ESTHER, the α/β fold family of proteins and the cholinesterase gene server. Nucleic Acids Res. 26, 226-228.
27. Clauser, K. R., Baker, P. R., and Burlingame, A. L. (1999) Role of accurate mass measurement (±10 ppm) in protein identification strategies employing MS or MS/MS and database searching. Anal. Chem. 71, 2871.
28. Issaq, H. J., Veenstra, T. D., Conrads, T. P., and Felshow, D. (2002) The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem. Biophys. Res. Commun. 292, 587-592.
29. Saxena, A., Raveh, L., Ashani, Y., and Doctor, B. P. (1997) Structure of glycan moieties responsible for the extended circulatory life time of fetal bovine serum acetylcholinesterase and equine serum butyryl-cholinesterase. Biochemistry 36, 7481-7489.
30. Eto, M. (1979) Organophosphorus Pesticides: Organic and Biological Chemistry. CRC Press, Boca Raton, FL.
31. Viragh, C., Harris, T. K., Reddy, P. M., Massiah, M. A., Mildvan, A. S., and Kovach, I. M. (2000) NMR evidence for a short, strong hydrogen bond at the active site of a cholinesterase. Biochemistry 39, 16200-16205.
32. Massiah, M. A., Viragh, C., Reddy, P. M., Kovach, I. M., Johnson, J., Rosenberry, T. L., and Mildvan, A. S. (2001) Short, strong hydrogen bonds at the active site of human acetylcholinesterase: proton NMR studies. Biochemistry 40, 5682-5690.
33. Jakubowski, E. M., Heycamp, L. S., Durst, H. D., and Thomson, S. A. (2001) Preliminary studies in the formation of ethyl methylphosphonofluoridate from rat and human serum exposed to VX and treated with fluoride ion. Anal. Lett. 34, 727-737,
34. Matsuda, Y., Nagao, M., Talatori, T., Niijima, H., Nakajima, M., Iwase, H., Kobayashi, M., and Iwadate, K. (1998) Detection of the sarin hydrolysis product in formalin-fixed brain tissues of victims of the Tokyo subway terrorist attack. Toxicol. Appl. Pharmacol. 150, 310-320.
35. Nagao, M., Takatori, T., Matsuda, Y., Nakajima, M., Iwase, H., and Iwadate, K. (1997) Definitive evidence for the acute sarin poisoning diagnosis in the Tokyo subway. Toxicol. Appl. Pharmacol. 144, 193-203.
36. Polhuijs, M., Langenberg, J. P. and Benschop, H. P. (1997) New method for retrospective detection of exposure to organophosphorus anticholinesterases: application to alleged sarin victims of Japanese terrorists. Toxicol. Appl. Pharmacol. 146, 156-161.
37. van der Schans, M. J., Polhuijs, M., van Dijk, C., Degenhardt, C. E., Pleijsier, K., Langenberg, J. P., and Benchop, H. P. (2004) Retrospective detection of exposure to nerve agents: analysis of phosphofluoridates originating from fluoride-induced reactivation of phosphylated BuChE. Arch. Toxicol. 78, 508-524.
38. George, K. M., Schule, T., Sandoval, L. E., Jennings, L. L., Taylor, P., and Thompson, C. M. (2003) Differentiation between acetylcholinesterase and the organophosphate-inhibited form using antibodies and the correlation of antibody recognition with reactivation mechanism and rate. J. Biol. Chem. 278, 45512-45518.
39. Tsuge, K., and Seto, Y. (2006) Detection of human butyrylcholinesterase- nerve gas adducts by liquid chromatography-mass spectrometric analysis after in gel chymotryptic digestion. J. Chromatogr., B 838, 21-30.
40. Noort, D., Fidder, A., van der Schans, M. J., and Hulst, A. G. (2006) Verification of exposure to organophosphates: generic mass spectrometric method for detection of human butyrylcholinesterase adducts. Anal. Chem. 78, 6640-6644.